SCHEMBL4629178

SCHEMBL4629178

O=C(O)C1CCCN1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ITGB3 P05106 1/20 0.46
ITGB1 P05556 1/20 0.46
ITGAV P06756 1/20 0.46
ITGA5 P08648 1/20 0.46
ITGA4 P13612 1/20 0.46
CYP2C19 P33261 1/20 0.43
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A2 P05177 1/20 0.41
SLC6A1 P30531 2/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
SLC6A11 P48066 1/20 0.40
ACE P12821 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4629180 1.00 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2ITGB3ITGB1ITGAV
SCHEMBL17923185 0.95 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2ITGB3ITGB1ITGAV
SCHEMBL18040347 0.95 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2ITGB3ITGB1ITGAV
SCHEMBL5688778 0.90 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2ITGB3ITGB1ITGAV
SCHEMBL5688777 0.90 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2ITGB3ITGB1ITGAV
SCHEMBL5688772 0.90 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2ITGB3ITGB1ITGAV
SCHEMBL1802808 0.87 ELANE (0.42) ALDH1A1SMN1; SMN2ITGB3ITGB1ITGAV
SCHEMBL10519057 0.87 ELANE (0.42) ALDH1A1SMN1; SMN2ITGB3ITGB1ITGAV
SCHEMBL3486781 0.86 KCNN4 (0.41) ALDH1A1SMN1; SMN2ITGB3ITGB1ITGAV
SCHEMBL31696763 0.83 LTA4H (0.46) ALDH1A1ITGB3ITGB1ITGAVITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116209438-A Treatment of malignant diseases with SHP2 mutations using SOS1 inhibitors 锐新医药公司 2023-06-02 CN disclosed
EP-1917234-A1 TRITYLATION REACTIONS BASED ON METALLIC CATALYSIS Universita'Degli Studi di Roma "La Sapienza" (IT) 2008-05-07 EP disclosed
WO-2007009944-A1 TRITYLATION REACTIONS BASED ON METALLIC CATALYSIS Università degli Studi di Roma 'La Sapienza' (IT) 2007-01-25 WO disclosed
EP-0801644-A4 POLYARYLCARBAMOYLAZA -AND- CARBAMOYLALKANEDIOIC ACIDS RHONE POULENC RORER PHARMA (US) 2001-03-07 EP disclosed
EP-0801644-A1 POLYARYLCARBAMOYLAZA -AND- CARBAMOYLALKANEDIOIC ACIDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1997-10-22 EP disclosed
US-5556990-A SQUALENE SYNTHASE INHIBITORS, ANTICHOLESTEROL AGENTS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-09-17 US disclosed
WO-1996018615-A1 POLYARYLCARBAMOYLAZA -AND- CARBAMOYLALKANEDIOIC ACIDS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-06-20 WO disclosed